CA2255804A1 - Methode antitumorale par administration de derives de partricine - Google Patents

Methode antitumorale par administration de derives de partricine Download PDF

Info

Publication number
CA2255804A1
CA2255804A1 CA002255804A CA2255804A CA2255804A1 CA 2255804 A1 CA2255804 A1 CA 2255804A1 CA 002255804 A CA002255804 A CA 002255804A CA 2255804 A CA2255804 A CA 2255804A CA 2255804 A1 CA2255804 A1 CA 2255804A1
Authority
CA
Canada
Prior art keywords
antitumoral
administration
partricin
derivatives
partricin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002255804A
Other languages
English (en)
Other versions
CA2255804C (fr
Inventor
Tiberio Bruzzese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pro Aparts Investimentos e Consultoria Ltda
Original Assignee
Quatex NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quatex NV filed Critical Quatex NV
Priority to CA002255804A priority Critical patent/CA2255804C/fr
Priority to US09/258,822 priority patent/US6121244A/en
Publication of CA2255804A1 publication Critical patent/CA2255804A1/fr
Application granted granted Critical
Publication of CA2255804C publication Critical patent/CA2255804C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
CA002255804A 1997-09-19 1998-12-07 Methode antitumorale par administration de derives de partricine Expired - Fee Related CA2255804C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002255804A CA2255804C (fr) 1998-12-07 1998-12-07 Methode antitumorale par administration de derives de partricine
US09/258,822 US6121244A (en) 1997-09-19 1999-02-26 Antitumoral method by administration of partricin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002255804A CA2255804C (fr) 1998-12-07 1998-12-07 Methode antitumorale par administration de derives de partricine

Publications (2)

Publication Number Publication Date
CA2255804A1 true CA2255804A1 (fr) 2000-06-07
CA2255804C CA2255804C (fr) 2009-07-28

Family

ID=29425801

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002255804A Expired - Fee Related CA2255804C (fr) 1997-09-19 1998-12-07 Methode antitumorale par administration de derives de partricine

Country Status (1)

Country Link
CA (1) CA2255804C (fr)

Also Published As

Publication number Publication date
CA2255804C (fr) 2009-07-28

Similar Documents

Publication Publication Date Title
CA2346011A1 (fr) Matrices a nanofibres hybrides s'utilisant comme dispositifs de genie tissulaire
CA2287470A1 (fr) Trifluoromethylalkylamino-triazolopyrimidines fongicides
IL80495A0 (en) Microbial compositions,their production and their use for treating soil
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
CA2026915A1 (fr) Facteurs de cellule souche
CA2193337A1 (fr) Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
CA2361920A1 (fr) Systeme de transport
CA2428450A1 (fr) Prothese corporelle
AU6973991A (en) Therapeutically active chloro substituted benzimidazoles, processes for their preparation as well as their use
FI963103A0 (fi) Ei-virusvektori
CA2230819A1 (fr) Medicament comprenant le gene hgf
HK74787A (en) Anthracycline glycosides
ZA997176B (en) Derivatives of erythromycin, their preparation process and their use as medicaments.
AU2910289A (en) Rotator for crane-mounted working implements, especially tree-processing units
DE69920949D1 (de) Ascomycin enthaltende topische zubereitungen
AU5290199A (en) Erythromycin derivatives with antibiotic activity
AU8213487A (en) Anthracycline derivatives having cytostatic activity
MY126362A (en) Novel pyrimido [1,2-a] indoles
CA2063273A1 (fr) Surfactants pulmonaires et methodes
AU4391199A (en) Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose
AU591174B2 (en) Imidazoles, their preparation and their use as fungicides
CA2358997A1 (fr) Outil de reduction de frottement et son procede d'utilisation dans un forage
CA2022553A1 (fr) Contenant en forme de livre pour faire pousser des semis
IE802033L (en) Dibenzazepine derivatives
NZ243202A (en) Glycosylated avermectin derivatives; their preparation by fermentation, their use as parasiticides

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20131209